Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome.

Abstract excerpt

GOALS: To assess the impact of interferon treatment on celiac disease onset in hepatitis C patients and to clarify its clinical relevance and outcome. BACKGROUND: Hepatitis C is associated with autoimmunity, which can be exacerbated by interferon treatment. Cases of celiac disease activation during interferon treatment have been reported. STUDY: Retrospective evaluation of 534 hepatitis C patients with or without...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Age of Onset
• Share to Antiviral Agents